ANNE OCELLO: Open Payments
NPI 1164773156 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 47 payments from 18 companies in 2025. Trend: 2023 $1,341 · 2024 $1,205 · 2025 $1,476
Food & beverage: $1,420Education: $56
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 8 | $314 |
| Biogen, Inc. | 9 | $292 |
| TG Therapeutics, Inc. | 4 | $219 |
| SK Life Science, Inc. | 4 | $94 |
| Alexion Pharmaceuticals, Inc. | 3 | $86 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| GENZYME CORPORATION | 1 | $47 |
| ABBVIE INC. | 2 | $46 |
| ARGENX US, INC. | 2 | $46 |
Products named: VUMERITY, BRIUMVI, Mavenclad, ULTOMIRIS, ACTHAR, KESIMPTA, QULIPTA, ZEPOSIA.
Industry payments across NY — which companies pay providers there.
